Murat Kalayoglu - Jan 2, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director, 10%+ Owner
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Murat Kalayoglu
Stock symbol
RNAC
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 05:04 PM
Previous filing
Nov 15, 2023
Next filing
Apr 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Award $0 +178K +69.06% $0.00 436K Jan 2, 2024 Direct F1
holding RNAC Common Stock 3.3M Jan 2, 2024 by trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Award $0 +228K $0.00 228K Jan 2, 2024 Common Stock 228K $0.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.
F2 Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.
F3 This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027.

Remarks:

Exhibit 24 - Power of Attorney